Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	0.5 mg GSK1278863	21
Overall Study	STARTED	2 mg GSK1278863	21
Overall Study	STARTED	5 mg GSK1278863	21
Overall Study	STARTED	rhEPO	20
Overall Study	COMPLETED	0.5 mg GSK1278863	17
Overall Study	COMPLETED	2 mg GSK1278863	17
Overall Study	COMPLETED	5 mg GSK1278863	17
Overall Study	COMPLETED	rhEPO	19
Overall Study	NOT COMPLETED	0.5 mg GSK1278863	4
Overall Study	NOT COMPLETED	2 mg GSK1278863	4
Overall Study	NOT COMPLETED	5 mg GSK1278863	4
Overall Study	NOT COMPLETED	rhEPO	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01587924/flow